Correction: Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2 (Clinical Cancer Research (2009) 15, (5032-5039))

G. D. Evans; M. Kalamarides; K. Hunter-Schaedle

doi:10.1158/1078-0432.CCR-09-2833

Correction: Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2 (Clinical Cancer Research (2009) 15, (5032-5039))

G. D. Evans, M. Kalamarides, K. Hunter-Schaedle

Division of Evolution, Infection and Genomics

Research output: Contribution to journal › Commentary/debate › peer-review

Original language	English
Number of pages	1
Journal	Clinical Cancer Research
Volume	15
Issue number	23
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-2833
Publication status	Published - 1 Dec 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-09-2833

Cite this

@article{8bb1b9d98188422d89ad3eaddfae96e1,

title = "Correction: Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2 (Clinical Cancer Research (2009) 15, (5032-5039))",

author = "Evans, {G. D.} and M. Kalamarides and K. Hunter-Schaedle",

year = "2009",

month = dec,

day = "1",

doi = "10.1158/1078-0432.CCR-09-2833",

language = "English",

volume = "15",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "23",

}

TY - JOUR

T1 - Correction

T2 - Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2 (Clinical Cancer Research (2009) 15, (5032-5039))

AU - Evans, G. D.

AU - Kalamarides, M.

AU - Hunter-Schaedle, K.

PY - 2009/12/1

Y1 - 2009/12/1

UR - http://www.scopus.com/inward/record.url?scp=73149089499&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-09-2833

DO - 10.1158/1078-0432.CCR-09-2833

M3 - Commentary/debate

AN - SCOPUS:73149089499

SN - 1078-0432

VL - 15

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 23

ER -

Correction: Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2 (Clinical Cancer Research (2009) 15, (5032-5039))

UN SDGs

Access to Document

Other files and links

Cite this